Arcturus Therapeutics Ltd. Development Stage Enterprise, Deficit Accumulated During Development Stage (Deprecated 2015-01-31)
Arcturus Therapeutics Ltd. had Development Stage Enterprise, Deficit Accumulated During Development Stage (Deprecated 2015-01-31) of $51.57 million as of 2014-12-31, per its 20-F filed 2015-02-27.
Discontinued › Notes
us-gaap:DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage · last filed 2015-02-27
- 2014-12-31: Development Stage Enterprise, Deficit Accumulated During Development Stage (Deprecated 2015-01-31) $51.57M.
- 2013-12-31: Development Stage Enterprise, Deficit Accumulated During Development Stage (Deprecated 2015-01-31) $18.73M.
- 2012-12-31: Development Stage Enterprise, Deficit Accumulated During Development Stage (Deprecated 2015-01-31) $8.19M.
| Period end | Development Stage Enterprise, Deficit Accumulated During Development Stage (Deprecated 2015-01-31) |
|---|---|
| 2014-12-31 | $51.57M 20-F · filed 2015-02-27 |
| 2013-12-31 | $18.73M 20-F · filed 2015-02-27 |
| 2012-12-31 | $8.19M 20-F · filed 2014-03-28 |